135 related articles for article (PubMed ID: 37080268)
1. Nanotechnology-empowered lung cancer therapy: From EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis.
Saleem HM; Ramaiah P; Gupta J; Jalil AT; Kadhim NA; Alsaikhan F; Ramírez-Coronel AA; Tayyib NA; Guo Q
Environ Res; 2023 Sep; 232():115942. PubMed ID: 37080268
[TBL] [Abstract][Full Text] [Related]
2. New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials.
He P; Dai Q; Wu X
Environ Res; 2023 Jul; 229():115672. PubMed ID: 36906272
[TBL] [Abstract][Full Text] [Related]
3. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint.
Alqurashi YE; Al-Hetty HRAK; Ramaiah P; Fazaa AH; Jalil AT; Alsaikhan F; Gupta J; Ramírez-Coronel AA; Tayyib NA; Peng H
Environ Res; 2023 Jun; 227():115683. PubMed ID: 36933639
[TBL] [Abstract][Full Text] [Related]
4. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
5. STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M; Entezari M; Orouei S; Ghollasi M; Fathi N; Rezaei S; Hejazi ES; Kakavand A; Saebfar H; Hashemi M; Goharrizi MASB; Salimimoghadam S; Rashidi M; Taheriazam A; Samarghandian S
Pharmacol Res; 2022 Aug; 182():106311. PubMed ID: 35716914
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
8. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.
Shi ZM; Wang L; Shen H; Jiang CF; Ge X; Li DM; Wen YY; Sun HR; Pan MH; Li W; Shu YQ; Liu LZ; Peiper SC; He J; Jiang BH
Oncogene; 2017 May; 36(18):2577-2588. PubMed ID: 28192397
[TBL] [Abstract][Full Text] [Related]
10. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
11. The EMT regulator slug and lung carcinogenesis.
Shih JY; Yang PC
Carcinogenesis; 2011 Sep; 32(9):1299-304. PubMed ID: 21665887
[TBL] [Abstract][Full Text] [Related]
12. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
13. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
14. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds.
Ang HL; Mohan CD; Shanmugam MK; Leong HC; Makvandi P; Rangappa KS; Bishayee A; Kumar AP; Sethi G
Med Res Rev; 2023 Jul; 43(4):1141-1200. PubMed ID: 36929669
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy.
Ashrafizadeh M; Shahinozzaman M; Orouei S; Zarrin V; Hushmandi K; Hashemi F; Kumar A; Samarghandian S; Najafi M; Zarrabi A
Curr Cancer Drug Targets; 2021; 21(8):640-665. PubMed ID: 33535952
[TBL] [Abstract][Full Text] [Related]
17. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
18. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
[TBL] [Abstract][Full Text] [Related]
19. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
[TBL] [Abstract][Full Text] [Related]
20. NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition.
Mirzaei S; Saghari S; Bassiri F; Raesi R; Zarrabi A; Hushmandi K; Sethi G; Tergaonkar V
J Cell Physiol; 2022 Jul; 237(7):2770-2795. PubMed ID: 35561232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
